Advanced search×

Primer site polymorphisms: potential implications for bone marrow engraftment monitoring.

Audio, Transactions of the IRE Professiona... 13(3):415-9 (2009) PMID 19405877

Assessment of chimerism after allogeneic bone marrow transplant frequently relies on PCR amplification of donor- and recipient-specific polymorphic short tandem repeats (STR) with subsequent fluorescent detection of amplicons. In vitro amplification of STR loci is often achieved through commercially available, multiplex PCR kits. While originally developed for forensic purposes, these kits are increasingly being used in clinical laboratories for early detection of graft failure and relapse of disease. Despite the obvious benefits of sensitivity, accuracy, reproducibility, and ease-of-use of these commercial kits, laboratories must understand the technological shortcomings of such assays to avoid misinterpretation of patient results. The current case illustrates how primer site polymorphisms associated with specific STR alleles can potentially lead to erroneous interpretation of engraftment analysis using one of these multiplex STR kits.

DOI: 10.1089/gtmb.2008.0153
Version: za2963e q8zab q8zb6 q8zc7 q8zda q8ze7 q8zfb q8zge

Similar articles you may find interesting…

  1. Computational Identification of a New Binding Site in Influenza Virus Hemagglutinin for Membrane Fusion Inhibitors.

    Chem Biol Drug Des (2013) PMID 23647909

    We investigated the possible HA binding sites for the current membrane-fusion inhibitors. Four possible binding pockets (Pocket A, B, C, and D) at the stalk region of HA were detected and defined by using the CAVITY program. Most of the current membrane-fusion inhibitors were reported to bind to Poc...
  2. Implication of higher BAALC expression in combination with other gene mutations in adult cytogenetically normal AML.

    Leuk Lymphoma (2013) PMID 23647058

    ABSTRACT Data of 125 patients of cytogenetically normal acute myeloid leukemia (CN-AML) regarding BAALC and combinatorial molecular markers at diagnosis were evaluated. Fewer patients with higher BAALC expression at diagnosis achieved complete remission (CR) (49.2 vs. 75.8%, p=0.002)...
  3. Cancer: a "stem-cell" disease?

    Cancer Cell Int 13(1):40 (2013) PMID 23647946

    We believe that cancer is a genetic disease. We focus on the genetic targets and epigenetic changes in a tumor. Remarkably, many crucial signal pathways in a malignant cell involve "stem-ness" genes. The prevalence of stem-ness in cancer suggests that cancer has a stem-cell origin and is a stem-cell...